| Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses C Cui, J Wang, E Fagerberg, PM Chen, KA Connolly, M Damo, ... Cell 184 (25), 6101-6118. e13, 2021 | 326 | 2021 |
| A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response KA Connolly, M Kuchroo, A Venkat, A Khatun, J Wang, I William, ... Science immunology 6 (64), eabg7836, 2021 | 254 | 2021 |
| Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells AC Wells, KA Daniels, CC Angelou, E Fagerberg, AS Burnside, ... Elife 6, e26398, 2017 | 89 | 2017 |
| PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens M Damo, NI Hornick, A Venkat, I William, K Clulo, S Venkatesan, J He, ... Nature 619 (7968), 151-159, 2023 | 36 | 2023 |
| A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma B Fitzgerald, KA Connolly, C Cui, E Fagerberg, DL Mariuzza, NI Hornick, ... Cell reports methods 1 (5), 2021 | 30 | 2021 |
| A reservoir of stem-like CD8 (+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 KA Connolly, M Kuchroo, A Venkat, A Khatun, J Wang, I William, ... | 18 | 2021 |
| Survival of Naïve T cells requires the expression of Let-7 miRNAs EL Pobezinskaya, AC Wells, CC Angelou, E Fagerberg, E Aral, E Iverson, ... Frontiers in immunology 10, 955, 2019 | 16 | 2019 |
| Intestinal tuft cell immune privilege enables norovirus persistence MS Strine, E Fagerberg, PW Darcy, GM Barrón, RB Filler, MM Alfajaro, ... Science Immunology 9 (93), eadi7038, 2024 | 3 | 2024 |
| Mapping the gene space at single-cell resolution with gene signal pattern analysis A Venkat, S Leone, SE Youlten, E Fagerberg, J Attanasio, NS Joshi, ... bioRxiv, 2023.11. 26.568492, 2023 | 1 | 2023 |
| Mapping the gene space at single-cell resolution with gene signal pattern analysis A Venkat, S Leone, SE Youlten, E Fagerberg, J Attanasio, NS Joshi, ... Nature Computational Science 4 (12), 955-977, 2024 | | 2024 |
| Abstract C101: Comprehensive identification of novel therapeutic targets for treatment of PD-1 resistant solid tumors via a genome-scale CRISPR/Cas9 in vivo T-cell screen IL Mercier, JJ Merkin, S Keegan, C Calnan, AF Hohmann, N Colletti, ... Molecular Cancer Therapeutics 18 (12_Supplement), C101-C101, 2019 | | 2019 |
| Comprehensive Identification of Novel Therapeutic Targets for Treatment of PD-1 Resistant Solid Tumors via a Genome-Scale CRISPR/Cas9 in vivo T-cell Screen I Le Mercier, JJ Merkin, S Keegan, C Calnan, AF Hohmann, N Colletti, ... MOLECULAR CANCER THERAPEUTICS 18 (12), 2019 | | 2019 |
| An Immune-CRISPRomics platform enabling genome-scale and pair-wise combination in vivo T-cell function screens enables comprehensive identification of novel therapeutic targets I Le Mercier, JJ Merkin, S Keegan, C Calnan, AF Hohmann, N Colletti, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
